Article: Wampole Laboratories Signs Agreement to Acquire Exclusive U.S. Distribution Rights for Efoora's Rapid HIV Test.

Article: Clearview ULTRA FOB Now Available; Inverness Medical Innovations ...
PR Newswire;  March 10, 2005 ;     668 words ... ... Innovations, Inc., and its subsidiary, Wampole Laboratories, LLC, announces the availability ... Bridgen, Ph.D., president, Wampole Laboratories. The American Cancer Society ... to about 40,000 deaths. About Wampole Laboratories Wampole Laboratories is committed ...

Article: Calypte Biomedical Announces Collaboration with Wampole ...
Business Wire;  January 24, 2000 ;     700+ words ... ... entered into a collaboration with Wampole Laboratories, a division of Carter Wallace ... Calypte Biomedical Corporation. Wampole Laboratories, which was appointed as Calypte ... uot; John Bridgen, President of Wampole Laboratories, said, &uot;Wampole ...

Article: MedPointe Announces Sale of Wampole Laboratories; ...
Business Wire;  August 8, 2002 ;     700+ words ... ... MedPointe's medical diagnostics division, Wampole Laboratories. The $70 million cash transaction, which has ... information on MedPointe, Wallace Pharmaceuticals or Wampole Laboratories, visit www.medpointeinc.com.

Article: MedPointe Completes Sale of Wampole Laboratories; ...
Business Wire;  September 23, 2002 ;     507 words ... ... announced that it has completed the divestiture of its Wampole Laboratories medical diagnostics division to Inverness Medical Innovations ... 8. Under the terms of the sale, Inverness purchased Wampole Laboratories and all of the assets required to operate its business ...

Article: CLARK LABORATORIES AND WAMPOLE LABORATORIES ...
PR Newswire;  July 31, 1995 ;     645 words ... ... Laboratories, Inc., announced today that it had entered into a non-binding Letter of Intent to provide the Wampole Laboratories Division of Carter-Wallace, Inc. (NYSE: CAR), with exclusive domestic marketing rights to its entire ...

Article: Inverness Medical Innovations' Subsidiary Wampole ...
PR Newswire;  July 11, 2005 ;     700+ words ... ... July 11 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. announced today that its subsidiary Wampole Laboratories has signed an agreement with Roche Diagnostics to collaborate on the first fully automated diagnostic test for ...

Article: Homocysteine ELISA may help identify patients at risk for ...
Medical Laboratory Observer;  February 1, 2002 ;     700+ words ... ... diagnosis and treatment of patients suspected of having hyperhomocysteinemia and homocystinuria has been released by Wampole Laboratories, Cranbury, NJ. Numerous studies have linked elevated levels of homocysteine to an increased risk of arteriosclerotic ...